Clinical Trials

The quiet disappearance of radiation oncology facilities across the American heartland is carving out vast healthcare voids that fundamentally threaten the survival prospects of millions of rural residents. While aggregate statistics often suggest that the national healthcare infrastructure remains

The traditional medical library, once defined by towering shelves of heavy leather-bound volumes and mountains of printed research papers, is rapidly evolving into a streamlined digital ecosystem where answers arrive in the blink of an eye. For decades, practitioners have relied on the steady but

Ivan Kairatov stands at the crossroads of a historic transformation in medicine, having spent years navigating the high-stakes world of biopharmaceutical research and development. As an expert with deep roots in both the technical and innovative corridors of the industry, he has witnessed the slow,

The regulatory landscape for pharmaceutical development has reached a definitive turning point as the U.S. Food and Drug Administration officially moves away from the decades-old requirement of two pivotal clinical trials in favor of a streamlined, single-trial default for new drug approvals. This

The persistent challenge of treating metastatic castration-resistant prostate cancer has long centered on the tumor’s ability to remain invisible to the body’s natural immune defenses while resisting standard therapeutic interventions. A groundbreaking preclinical study led by researchers at Weill

The cardiovascular research community stood in stunned silence this week as a once-heralded clinical champion stumbled at the very finish line of its long journey toward regulatory approval. Shares of Ionis Pharmaceuticals plummeted by 21% in early trading, while AstraZeneca faced an 8% drop,